##1: Challenges in Rare Variant Analysis and the Need for Masking Rare Variant Association Tests are essential tools for uncovering disease etiology, yet effectively filtering out irrelevant common variants has long been a methodological hurdle. In large‑scale cohorts such as the UK Biobank, inappropriate masking strategies can diminish reproducibility and weaken statistical power.

##2: Deriving the Optimal Masking Strategy Through Empirical Comparison The research team systematically compared multiple masking approaches across 54 phenotypes in the UK Biobank. By precisely integrating allele frequency, protein‑function prediction scores, and intragenic positional information, the new masking strategy achieved significantly higher power than conventional methods. This refinement is akin to sharpening a map that isolates true genetic signals within complex data.

##3: Improved Power and Replicability From Precise Masking The study establishes a "baseline masking strategy" that redefines design principles for gene‑level burden tests. Applying this strategy dramatically enhanced result reproducibility across diverse research settings, enabling more definitive characterization of rare‑variant contributions to disease.

##4: Building a Standard Pipeline and Extending to Precision Medicine Integration of this masking strategy into standard analysis pipelines will elevate the reliability of rare‑disease genetics research. Applying it to broader ancestry and disease cohorts will improve individual genetic risk prediction and accelerate the discovery of personalized prevention and therapeutic targets, thereby advancing data‑driven precision medicine.